48TiPKEYNOTE-122: Phase 2 study of pembrolizumab versus standard-of-care chemotherapy in platinum-pretreated, recurrent or metastatic nasopharyngeal carcinoma
Ng, Q.S., Spreafico, A., Lee, V., Ngan, R.K.C., To, K.F., Ahn, M-J., Hong, R-L., Lin, J- C., Swaby, R.F., Chan, A.T.C.Volume:
27
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw525.48
Date:
November, 2016
File:
PDF, 50 KB
english, 2016